AzTrials
AzTrials

StrokeSHIVCNCT07207330

Stroke Code in Hospitals From Villavicencio, Colombia

An observational study of Stroke and Ischemic Stroke, run by Hospital Departamental de Villavicencio at 1 site in Colombia.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This is a descriptive cross-sectional study to evaluate stroke events in a hospital in the Orinoco region. It is based on reviewing a database obtained by routinely uploading patient information. Read more about this study

Who is it for?
Ages 40 to 100 years
Conditions the study is for
Stroke, Ischemic Stroke
How many people
100 participants
Where
1 siteColombia
Study dates
1 Jan 2025to Apr 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients admited to the emergency room

Who may be able to join

  • Adult
  • Clinical diagnosis of stroke
  • CT findings compatible with a stroke

Who cannot join

  • Trauma

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Norton Perez, MD contact

+573112517471

norton.perez@hotmail.com

Harold Gaitan Sierra, MD contact

Colombia1 site, 1 recruiting

  • Clinica Primavera

    Villavicencio, Meta Department, 50001

    Norton Perez, MD, 3112517471, norton.perez@hotmail.com

    Recruiting

Other trials in Colombia

About this study

Official title: Stroke Code: an Observational Cross-sectional Trial in Hospitals From Villavicencio, Colombia

This is a descriptive cross-sectional study to evaluate stroke events in a hospital in the Orinoco region. It is based on reviewing a database obtained by routinely uploading patient information. The registry is designed to follow up on the activation of a stroke code for clinical purposes and as an internal communication strategy. All registries are reviewed monthly in a scientific committee to improve quality of healthcare, standardize therapeutic strategies, and optimize outcomes. The review of the registries will allow to recognize patterns of care, delays in treatment, and define adherence to guidelines.

Read the detailed description

Background: Data banks or stroke registries are collected in several countries worldwide, generating information that improves patient healthcare quality.

Aim: The study aims to describe the stroke registry of patients admitted to a high-median-complexity institution.

Methodology: We wil perform a cross-sectional trial. Demographic and disease data, as well as discharge outcomes, are systematically collected in the RES-Q database. The records from the study period will be downloaded in Excel for evaluation. Numeric variables were assessed in their central distribution and dispersion, while categorical variables were presented in frequency and proportion.

Reports of stroke events in Latin America are scarce, and none were from the Colombian Orinoco region, even though there are multiple publications in the scientific literature about the use of clinical registries for stroke.

Keywords
Stroke, Ischemic Stroke
Medical subject headings
Stroke, Ischemic Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07207330
Study groupRoleWhat they receive
Study groupRegistries of patients admitted to the emergency room with stroke suspicion by neurological deficit or headache.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional condition

    Modified Rankin in 3 or below

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2025
  2. Study start1 Jan 2025
  3. Primary completionDec 2026 (estimated)
  4. Study completionApr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07207330
Sponsor's protocol ID
GRIVI_2025_01_Stroke
Acronym
SHIVC
Status last verified
Sep 2025
First submitted
1 Sep 2025
Last updated
3 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The data contains personal information of patients restricted to hospital officials.

Publications

  • Lou M, Ding J, Hu B, Zhang Y, Li H, Tan Z, Wan Y, Xu AD; Chinese Stroke Association Stroke Council Guideline Writing Committee. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update on organizational stroke management. Stroke Vasc Neurol. 2020 Sep;5(3):260-269. doi: 10.1136/svn-2020-000355. Epub 2020 Jul 8.

    PubMed 32641444

  • Dhand A, Reeves MJ, Mu Y, Rosner BA, Rothfeld-Wehrwein ZR, Nieves A, Dhongade VA, Jarman M, Bergmark RW, Semco RS, Ader J, Marshall BDL, Goedel WC, Fonarow GC, Smith EE, Saver JL, Schwamm LH, Sheth KN. Mapping the Ecological Terrain of Stroke Prehospital Delay: A Nationwide Registry Study. Stroke. 2024 Jun;55(6):1507-1516. doi: 10.1161/STROKEAHA.123.045521. Epub 2024 May 24.

    PubMed 38787926

  • Fasugba O, Sedani R, Mikulik R, Dale S, Varecha M, Coughlan K, McElduff B, McInnes E, Hladikova S, Cadilhac DA, Middleton S. How registry data are used to inform activities for stroke care quality improvement across 55 countries: A cross-sectional survey of Registry of Stroke Care Quality (RES-Q) hospitals. Eur J Neurol. 2024 Jan;31(1):e16024. doi: 10.1111/ene.16024. Epub 2023 Aug 21.

    PubMed 37540834

  • Gimenez-Munoz A, Ara JR, Abad Diez JM, Campello Morer I, Perez Trullen JM. Trends in stroke hospitalisation rates and in-hospital mortality in Aragon, 1998-2010. Neurologia (Engl Ed). 2018 May;33(4):224-232. doi: 10.1016/j.nrl.2016.06.013. Epub 2016 Aug 21. English, Spanish.

    PubMed 27554162

  • Posadas-Martinez ML, Vicens J, Dawidowski AR, Martinez Von Scheidt MA, Pagotto VL, Blugerman GA, Schpilberg MG, Gadano AC. The role of registries in improving health and bridging healthcare, research, education, innovation and development: a research department perspective. J Int Med Res. 2024 Mar;52(3):3000605241233140. doi: 10.1177/03000605241233140.

    PubMed 38460545

  • Matuja SS, Ngimbwa J, Andrew L, Shindika J, Nchasi G, Kasala A, Paul IK, Ndalahwa M, Mawazo A, Kalokola F, Ngoya P, Rudovick L, Kilonzo S, Wajanga B, Massaga F, Kalluvya SE, Munseri P, Mnacho MA, Okeng'o K, Kimambo H, Manji M, Ruggajo P, Nagu T, Ahmed RA, Sheriff F, Mahawish K, Mangat H, Nguyen-Huynh MN, Saylor D, Peck R. Stroke characteristics and outcomes in urban Tanzania: Data from the Prospective Lake Zone Stroke Registry. Int J Stroke. 2024 Jun;19(5):536-546. doi: 10.1177/17474930231219584. Epub 2023 Dec 16.

    PubMed 38031727

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Ischemic Stroke, run by Hospital Departamental de Villavicencio at 1 site in Colombia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Colombia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Norton Perez, MD (+573112517471, norton.perez@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional condition (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07207330, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2025.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in